Transphorm Announces Fiscal Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Transphorm, Inc (TGAN) Tops Q2 EPS by 7c
November 10, 2021 4:27 PM ESTTransphorm, Inc (OTC: TGAN) reported Q2 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $11.3 million versus the consensus estimate of $11.63 million.
For earnings history and earnings-related data on Transphorm, Inc (TGAN) click here.
... More